Immatics N.V (NASDAQ: IMTX) on Friday, plunged -4.22% from the previous trading day, before settling in for the closing price of $8.53. Within the past 52 weeks, IMTX’s price has moved between $7.98 and $13.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 145.27% annually for the last half of the decade. The company achieved an average annual earnings per share of 30.15%. With a float of $88.97 million, this company’s outstanding shares have now reached $119.36 million.
In an organization with 343 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -35.07%, operating margin of -142.3%, and the pretax margin is -101.65%.
Immatics N.V (IMTX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immatics N.V is 25.29%, while institutional ownership is 61.69%.
Immatics N.V (IMTX) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.34 earnings per share (EPS) for the period topping the consensus outlook (set at -0.39) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.15% per share during the next fiscal year.
Immatics N.V (NASDAQ: IMTX) Trading Performance Indicators
Immatics N.V (IMTX) is currently performing well based on its current performance indicators. A quick ratio of 3.74 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.90, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.28 in one year’s time.
Technical Analysis of Immatics N.V (IMTX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.84 million. That was better than the volume of 0.49 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 16.74%. Additionally, its Average True Range was 0.40.
During the past 100 days, Immatics N.V’s (IMTX) raw stochastic average was set at 4.47%, which indicates a significant decrease from 14.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 34.84% in the past 14 days, which was lower than the 43.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.35, while its 200-day Moving Average is $11.26. However, in the short run, Immatics N.V’s stock first resistance to watch stands at $8.58. Second resistance stands at $8.99. The third major resistance level sits at $9.31. If the price goes on to break the first support level at $7.85, it is likely to go to the next support level at $7.53. The third support level lies at $7.12 if the price breaches the second support level.
Immatics N.V (NASDAQ: IMTX) Key Stats
Market capitalization of the company is 933.99 million based on 119,356K outstanding shares. Right now, sales total 58,440 K and income totals -104,980 K. The company made 20,200 K in profit during its latest quarter, and -19,410 K in sales during its previous quarter.
